Search results for “Adrenergic antagonist” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 381 patents, we discovered top 78 key players by total patent application. Abbott Laboratories, Novartis AG, Merck & Co., Inc. are dominant in this area. They take 22.31% of the total patent filing.
Abbott Laboratories
Illinois, United States
Patent: 37
Novartis AG
Basel-Stadt, Switzerland
Patent: 26
Merck & Co., Inc.
New Jersey, United States
Patent: 22
Ocuphire Pharma, Inc.
Michigan, United States
Patent: 22
Recordati SA Chemical & Pharmaceutical Co.
Switzerland
Patent: 17
Pfizer Products, Inc.
Connecticut, United States
Patent: 16
BIAL-Portela & Cia SA
Porto, Portugal
Patent: 12
Cellegy Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 12
Pharmacia Corp.
New Jersey, United States
Patent: 11
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 11
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Actimed Therapeutics Ltd.
United Kingdom
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 42 patents applied in the last 5 years. We discover 8 most active companies in this area. The fast-growing Ocuphire Pharma, Inc., Harrow IP LLC, Massachusetts Institute of Technology take 64.29% of patent filing during this period.
Ocuphire Pharma, Inc.
Michigan, United States
Patent: 22
Harrow IP LLC
California, United States
Patent: 3
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 2
Shire Human Genetic Therapies, Inc.
Massachusetts, United States
Patent: 2
Helperby Therapeutics Group Ltd.
United Kingdom
Patent: 1
Sun Pharmaceutical Industries Ltd.
Maharashtra, India
Patent: 1
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 1
South Dakota Board of Regents
South Dakota, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 42 patents in last 5 years, we discover 7 new entrants. Ocuphire Pharma, Inc., Harrow IP LLC, Massachusetts Institute of Technology are the most active new entrants in this area.
Ocuphire Pharma, Inc.
Michigan, United States
Patent: 22
Harrow IP LLC
California, United States
Patent: 3
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 2
Shire Human Genetic Therapies, Inc.
Massachusetts, United States
Patent: 2
Sun Pharmaceutical Industries Ltd.
Maharashtra, India
Patent: 1
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 1
South Dakota Board of Regents
South Dakota, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 31 patents, we discovered top 12 universities and scientific research institutions by total patent application. Centre Hospitalier Universitaire de Nice, University of Nice Sophia Antipolis, Massachusetts Institute of Technology are dominant in this area. They take 41.94% of the total patent filing.
Centre Hospitalier Universitaire de Nice
France
Patent: 3
University of Nice Sophia Antipolis
France
Patent: 3
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 2
Baylor College of Medicine
Texas, United States
Patent: 2
Federal University of Rio de Janeiro
Rio de Janeiro, Brazil
Patent: 2
University of California
California, United States
Patent: 1
Tongji University
Shanghai Shi, China
Patent: 1
Clemson University
South Carolina, United States
Patent: 1
Centre Hospitalier Universitaire de Bordeaux
France
Patent: 1
Universidade Federal de Minas Gerais
Minas Gerais, Brazil
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: